論文・総説 - 稲澤　譲治

41. Hirabayashi Kyoko, Uehara Daniela Tiaki, Abe Hidetoshi, Ishii Atsushi, Moriyama Keiji, Hirose Shinichi, Inazawa Johji. Copy number variation analysis in 83 children with early-onset developmental and epileptic encephalopathy after targeted resequencing of a 109-epilepsy gene panel(和訳中) Journal of Human Genetics. 2019.11; 64 (11): 1097-1106. ( 医中誌 )

42. Low SK, Chin YM, Ito H, Matsuo K, Tanikawa C, Matsuda K, Saito H, Sakurai-Yageta M, Nakaya N, Shimizu A, Nishizuka SS, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Takezaki T, Suzuki S, Naito M, Wakai K, Kamatani Y, Momozawa Y, Murakami Y, Inazawa J, Nakamura Y, Kubo M, Katagiri T, Miki Y. Identification of two novel breast cancer loci through large-scale genome-wide association study in the Japanese population. Scientific reports. 2019.11; 9 (1): 17332. ( PubMed, DOI )

43. Takata R, Takahashi A, Fujita M, Momozawa Y, Saunders EJ, Yamada H, Maejima K, Nakano K, Nishida Y, Hishida A, Matsuo K, Wakai K, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Sasaki M, Shimizu A, Tanno K, Minegishi N, Suzuki K, Matsuda K, Kubo M, Inazawa J, Egawa S, Haiman CA, Ogawa O, Obara W, Kamatani Y, Akamatsu S, Nakagawa H. 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. Nature communications. 2019.09; 10 (1): 4422. ( PubMed, DOI )

44. Akatsu Y, Takahashi N, Yoshimatsu Y, Kimuro S, Muramatsu T, Katsura A, Maishi N, Suzuki HI, Inazawa J, Hida K, Miyazono K, Watabe T. Fibroblast growth factor signals regulate transforming growth factor-β-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1. Molecular oncology. 2019.08; 13 (8): 1706-1724. ( PubMed, DOI )

45. Kikuchi-Koike R, Nagasaka K, Tsuda H, Ishii Y, Sakamoto M, Kikuchi Y, Fukui S, Miyagawa Y, Hiraike H, Kobayashi T, Kinoshita T, Kanai Y, Shibata T, Imoto I, Inazawa J, Matsubara O, Ayabe T. Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer. BMC cancer. 2019.05; 19 (1): 521. ( PubMed, DOI )

46. Tanikawa C, Kamatani Y, Toyoshima O, Sakamoto H, Ito H, Takahashi A, Momozawa Y, Hirata M, Fuse N, Takai-Igarashi T, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Hishida A, Wakai K, Furusyo N, Murakami Y, Nakamura Y, Imoto I, Inazawa J, Oze I, Sato N, Tanioka F, Sugimura H, Hirose H, Yoshida T, Matsuo K, Kubo M, Matsuda K. Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21. Cancer science. 2018.12; 109 (12): 4015-4024. ( PubMed, DOI )

47. Inazawa Johji. From genomic alterations to target genes for cancer therapy; miRNA therapeutics has emerged as a promising strategy CANCER SCIENCE. 2018.12; 109 1079.

48. Takagawa Yuki, Gen Yasuyuki, Muramatsu Tomoki, Harada Hiroyuki, Inazawa Johji. Exploring novel tumor suppressive microRNAs in OSCC CANCER SCIENCE. 2018.12; 109 1083.

49. Kishikawa Masahiro, Inoue Jun, Hamamoto Hidetoshi, Kobayashi Katsunori, Fujiwara Kyoko, Asakage Takahiro, Inazawa Johji. Therapeutic potential of the topical treatment of miR-634 ointment for skin cancer CANCER SCIENCE. 2018.12; 109 1012.

50. Gokita Kentaro, Inoue Jun, Ishihara Hiroshi, Kojima Kazuyuki, Inazawa Johji. Therapeutic potential of LNP-mediated delivery of miR-634 for cancer therapy CANCER SCIENCE. 2018.12; 109 253.

51. Gen Yasuyuki, Inoue Jun, Inazawa Johji. The exploration of miRNAs that induce cell death in p53-inactive cancer cells using functional-miRNA screening CANCER SCIENCE. 2018.12; 109 395.

52. Inoue Jun, Furusawa Akiko, Miyamoto Morikazu, Takano Masashi, Tsuda Hitoshi, Song Yong Sang, Aoki Daisuke, Miyasaka Naoyuki, Inazawa Johji. Ovarian cancer therapeutic potential of glutamine depletion based on GS expression CANCER SCIENCE. 2018.12; 109 330.

53. Takata Ryo, Akamatsu Shusuke, Nakagawa Hidewaki, Takahashi Atsushi, Terada Naoki, Kato Yoichiro, Kanehira Mitsugu, Sugimura Jun, Inazawa Johji, Ogawa Osamu, Obara Wataru. Identification of fourteen new susceptibility loci for prostate cancer in the Japanese population CANCER SCIENCE. 2018.12; 109 1142.

54. Tanikawa Chizu, Kamatani Yoichiro, Toyoshima Osamu, Sakamoto Hiromi, Ito Hidemi, Takahashi Atsushi, Momozawa Yukihide, Hirata Makoto, Fuse Nobuo, Takai-Igarashi Takako, Shimizu Atsushi, Sasaki Makoto, Yamaji Taiki, Sawada Norie, Iwasaki Motoki, Tsugane Shoichiro, Naito Mariko, Hishida Asahi, Wakai Kenji, Furusyo Norihiro, Murakami Yoshinori, Nakamura Yusuke, Imoto Issei, Inazawa Johji, Oze Isao, Sato Naomi, Tanioka Fumihiko, Sugimura Haruhiko, Hirose Hiroshi, Yoshida Teruhiko, Matsuo Keitaro, Kubo Michiaki, Matsuda Koichi. ゲノムワイド関連解析により12q24.11-12および20q11.21に胃癌感受性遺伝子座が同定される(Genome-wide association study identifies gastric cancer susceptibility loci at 12q24.11-12 and 20q11.21) Cancer Science. 2018.12; 109 (12): 4015-4024. ( 医中誌 )

55. Sato T, Muramatsu T, Tanabe M, Inazawa J. Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line. Cancer science. 2018.11; 109 (11): 3623-3633. ( PubMed, DOI )

56. Sato Taku, Muramatsu Tomoki, Tanabe Minoru, Inazawa Johji. 膵癌細胞株由来の循環腫瘍細胞系で誘導したトランスフォーミング成長因子βの同定と特性評価(Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line) Cancer Science. 2018.11; 109 (11): 3623-3633. ( 医中誌 )

57. Tanikawa C, Kamatani Y, Takahashi A, Momozawa Y, Leveque K, Nagayama S, Mimori K, Mori M, Ishii H, Inazawa J, Yasuda J, Tsuboi A, Shimizu A, Sasaki M, Yamaji T, Sawada N, Iwasaki M, Tsugane S, Naito M, Wakai K, Koyama T, Takezaki T, Yuji K, Murakami Y, Nakamura Y, Kubo M, Matsuda K. GWAS identifies two novel colorectal cancer loci at 16q24.1 and 20q13.12. Carcinogenesis. 2018.05; 39 (5): 652-660. ( PubMed, DOI )

58. Furusawa A, Miyamoto M, Takano M, Tsuda H, Song YS, Aoki D, Miyasaka N, Inazawa J, Inoue J. Ovarian cancer therapeutic potential of glutamine depletion based on GS expression. Carcinogenesis. 2018.05; 39 (6): 758-766. ( PubMed, DOI )

59. Tonouchi E, Gen Y, Muramatsu T, Hiramoto H, Tanimoto K, Inoue J, Inazawa J. Publisher Correction: miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein. Scientific reports. 2018.04; 8 (1): 6769. ( PubMed, DOI )

60. Tonouchi E, Gen Y, Muramatsu T, Hiramoto H, Tanimoto K, Inoue J, Inazawa J. miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein. Scientific reports. 2018.03; 8 (1): 4482. ( PubMed, DOI )